Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach
JACC: Cardiovascular Interventions · 2024
DOI: 10.1016/j.jcin.2024.06.003 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Luke P Dawson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Stanford University School of Medicine, Stanford, California, USA; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, …. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Artery Bypass, Coronary Artery Disease, Coronary Angiography. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Coronary disease complexity is commonly used to guide revascularization strategy in patients with multivessel disease (MVD). OBJECTIVES: The aim of this study was to assess the interactive effects of coronary complexity on percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) outcomes and identify the optimal threshold at which PCI can be considered a reasonable option. METHODS: A total of 1,444 of 1,500 patients with MVD from the FAME (Fractional Flow Reserve versus Angiography for Multi-vessel Evaluation) 3 randomized trial were included in the analysis (710 CABG vs 734 PCI). SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores were transformed into restricted cubic splines, and logistic regression models were fitted, with multiplicative interaction terms for revascularization strategy. Optimal thresholds at which PCI is a reasonable alternative to CABG were determined on the basis of Cox regression model performance. RESULTS: The mean SYNTAX score (SS) was 25.9 ± 7.1. SS was associated with 1-year major adverse cardiac and cerebrovascular events among PCI patients and 3-year death, myocardial infarction, and stroke among CABG patients. Significant interactions were present between revascularization strategy and SS for 1- and 3-year composite endpoints (P for interaction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanford University School of Medicine, Stanford, California, USA; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
- NewYork-Presbyterian Brooklyn Methodist Hospital, Weill Cornell Medical College, Brooklyn, New York, USA.
- Catharina Hospital, Eindhoven, the Netherlands.
- Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Stanford University School of Medicine, Stanford, California, USA.
- Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Zitieren
APA
Dawson, L. P., Kobayashi, Y., Zimmermann, F. M., Takahashi, T., Wong, C. C., Theriault-Lauzier, P., Pijls, N. H. J., De Bruyne, B., Yeung, A. C., Woo, Y. J., Fearon, W. F., & FAME 3 Trial Investigators (2024). Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.06.003
Vancouver
Dawson LP, Kobayashi Y, Zimmermann FM, Takahashi T, Wong CC, Theriault-Lauzier P, et al. Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.06.003
BibTeX
@article{Dawson2024,
author = {Dawson, Luke P and Kobayashi, Yuhei and Zimmermann, Frederik M and Takahashi, Tatsunori and Wong, Christopher C and Theriault-Lauzier, Pascal and Pijls, Nico H J and De Bruyne, Bernard and Yeung, Alan C and Woo, Y Joseph and Fearon, William F and FAME 3 Trial Investigators, FAME 3 Trial Investigators},
title = {Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
doi = {10.1016/j.jcin.2024.06.003}
}
EUVIMED